| SRRA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SRRA market cap history going back to 2/28/2017:
Also see: SRRA Shares Outstanding History and SRRA YTD Return |
SRRA Market Cap History — Sierra Oncology Capitalization Over Time
As of 5/2/2022 Sierra Oncology has a market cap of 1.33 billion. Investors often follow the SRRA market cap history to compare the size of the company over time.
This page shows SRRA market capitalization trends over time, with 25 market cap datapoints presented, dating back to 2/28/2017.
| SRRA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
SRRA Historical Market Cap: +72.76% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| SRRA Stock Price Chart |
| About Sierra Oncology Inc |
| Sierra Oncology is a late-stage biopharmaceutical company focused on therapies that treat cancer. Co.'s focus is the development and commercialization of momelotinib, an investigational agent for the treatment of myelofibrosis. Momelotinib is a small-molecule inhibitor of JAK1 (Janus kinase 1), JAK2 (Janus kinase 2) and ACVR1 (Activin A receptor type 1), under development for treatment of patients with myelofibrosis. Co. has conducted a review of data from the two Phase 3 trials of momelotinib, versus ruxolitinib and best available therapy, as well as GS-US-352-1672, a Phase 2, open-label, translational biology trial of momelotinib in transfusion-dependent subjects with myelofibrosis. We show 25 historical shares outstanding datapoints in our SRRA shares outstanding history coverage, used to compute SRRA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SRRA market cap history over the course of time is important for investors interested in comparing SRRA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SRRA versus a peer is one thing; comparing SRRA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SRRA can fluctuate over the course of history. With this page we aim to empower investors researching SRRA by allowing them to research the SRRA market cap history. |
| SRRA Current Stock Quote |
Quotes delayed 20 minutes  Free SRRA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SRRA Share Performance |
| Market Cap Peers |
| Sierra Oncology (SRRA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SRRK Market Cap History SRTS Market Cap History SRZN Market Cap History SSII Market Cap History SSKN Market Cap History STAA Market Cap History STAB Market Cap History STE Market Cap History STEX Market Cap History STIM Market Cap History More Healthcare companies » |
SRRA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
